[1] Tomoda M, Maehara Y, Kakeji Y, et al. Intratumoral neovascularization and growth pattern in early gastric carcinoma [J ].Cancer ,1999,85(11) :2340-2346
[2] 王辅林,韦立新, 陈乐真. 血管内皮生长因子、微血管密度与乳腺癌淋巴结转移及预后的关系[J]. 中华病理学杂志（Wang F L, Wei L X, Chen L Z.The relationship between vascular endothelial growth factor, microvascular density, lymph node metastasis and prognosis of breast carcinoma [J]. Chin J Pathol), 2000, 29(3):172-175
[3] Commeren D L, Van Soest P L, Karimi K,et al. Paradoxical effects of interleukin-10 on the maturation of murine myeloid dendritic cells[J]. Immunology,2003,110(2):188-196
[4] Ohm J E, Carbone D P. VEGF as a mediator of tumor-associated immunodeficiency[J]. Immunol Res, 2001,23(2-3):263-272
[5] Laxmanan S, Robertson S W, Wang E, et al. Vascular endothelial cell growth factor impairs the functional ability of dendritic cells through Id pathways [J].Biochem Biophys Res Commun, 2005, 334(1):193-198
[6] Almand B, Resser J R, Lindman B, et al. Clinical significance of defective dendritic cell differentiation in cancer [J]. Clin Cancer Res,2000, 6(5):1755-1766
[7] Orsini E, Guarini A, Chiaretti S, et al. The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response [J]. Cancer Res, 2003,63(15):4497-4506
[8] Dorsett Y, Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics [J]. Nat Rev Drug Discov, 2004,3(4):318-329
[9] Takei Y, Kadomatsu K, Yuzawa Y, et al. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics[J]. Cancer Res, 2004, 64(10):3365-3370
[10] 李霞，徐文华，曹明智,等. 下调VEGF基因表达对乳腺癌细胞MCF-7的增殖抑制作用[J]. 医学分子生物学（Li X, Xu W H, Cao M Z, et al. Inhibition of proliferation of breast cancer cells MCF-7 by down-regulating the expression of VEGF [J]. J Med Mol Biol), 2005, 2(4):262-265
[11] Restifo N P. Not so Fas: Re-evaluating the mechanisms of immune privige and tumor escape [J]. Nat med, 2000, 6(5): 493-495
[12]Thompson W D. The clinical manipulation of angiogenesis: pathology, side-effects , surprises and opportunities with novel　human therapies[J]. J Pathol, 2000, 190 (3):330-337
[13] Chung J, Yoon S, Datta K, et al. Hypoxia-induced vascular endothelial growth factor transcription and protection from apoptosis are dependent on alpha6beta1 integrin in breast carcinoma cells [J]. Cancer Res, 2004, 64 (14): 4711-4716
[14] Folkman J. Clinical application of research on angiogenesis[J]. N Eng J Med, 1995, 333 (26): 1757-1763
[15] Schuler G, Schuler-Thumer B, Steinman R M. The use of dendritic cells in cancer immunotherapy[J]. Curr Opin Immuno1, 2003, 15(2):138-147
[16] Nishioka Y, Hua W, Nishmun N, et al. Genetic modification of dendritic cells and its application for cancer immunotherapy[J]. J Med Invest, 2002,49(1-2): 7-17
[17] Wright-Browni V, Mcclain K L,Talpaz M, et al. Physiology and pathophysiology of dendritic cells[J]. Hum pathol,1997, 28(5): 563-579
[18] Ardavin C, Iartinez del Hoyo G, Iartin P, et al. Origin an differentiation of dendritic cells[J]. Trends Immunol,2001, 22(12): 691-700
[19] 张淑华,葛银林,罗达亚,等. 小干扰RNA靶向VEGF基因在体内外抑制乳腺癌细胞的增殖[J].中国生物化学与分子生物学报（Zhang S Y, Ge Y L, Luo D Y, et al. Small interfering RNAs directed against VEGF gene inhibit proliferation of breast cancer cells in vitro and in vivo[J]. Chin J Biochem Mol Biol), 2007,23(1):68-73
[20]Boussiotis V A, Freeman G J, Gray G, et al. B7 but not intercelluar adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance[J]. J Exp Med,1993,178(5):1753-1763
[21] Cuellar A, Fonseca A, Gomez A, et al. Effect of lipopolysaccharides on human dendritic cell cultures and its inhibition by polymyxin B[J]. Biomedica, 2004,24(4):413-422
[22] 席泓，古涛，朱一蓓. 凋亡肿瘤细胞负载的树突状细胞对抗原特异性CTL的激活[J]. 上海免疫学杂志（Xi H, Gu T, Zhu Y P. Study on tumor-specific cytotoxicity T lymphocytes activated by dendritic cells loaded with apoptotic tumor cells [J].Shanghai J Immunol), 2002, 22(5):297-300
[23] Banchereau J, Schucer-Thurner B, Palucka A K. Dendritic cell as vectors for therapy[J].Cell, 2001, 106(3):271-274